Peripheral Arterial Disease Clinical Trial
Official title:
Effects of Plant-Based Diet on Peripheral Arterial Disease
Cardiovascular disease (CVD), a condition predominantly caused by atherosclerosis, is the
leading cause of morbidity and mortality in the investigator's society. Peripheral arterial
disease (PAD), a subset of CVD, occurs when the atherosclerosis progresses to compromise the
lower extremity circulation resulting in ischemic symptoms. Although atherosclerosis has been
generally regarded as a disease of developed or affluent countries, recent evidence showed a
progressive rise in the prevalence of CVD in developing countries where an epidemiological
shift of disease prevalence patterns from infectious illnesses to atherosclerotic disease has
occurred. Management of CVD, particularly with an emphasis of disease prevention, will
undoubtedly play an increasing vital role in the health care system around the world.
Endothelial dysfunction, as reflected by the impaired arterial vasodilatory capacity,
represents one of the pathogenic mechanisms linking atherosclerosis and cardiovascular
mortality. The ability of arteries to dilate in response to stimuli is a significant
indicator of underlying vascular endothelial function and associated CVD. Factors modulating
vasodilatory response include the release of vasoactive compounds such as nitric oxide (NO)
from the endothelium and vascular compliance. In healthy individuals, a major mechanism
responsible for vasodilation is the hyperemic-stimulated release of NO from the endothelium,
resulting in vascular smooth muscle relaxation with subsequent vasodilation.
Vascular endothelial function can be assessed using a non-invasive technique to determine
brachial artery reactivity whereby a high-resolution ultrasound is used to measure changes in
brachial artery diameter to endogenous production of endothelium-derived NO via flow-mediated
dilation (FMD). Therefore, reduced FMD has been described as a reliable indicator of vascular
endothelial dysfunction as well as presence of underlying CVD risk factors and related
diseases. Recent studies have similarly shown that arterial pulse-wave velocity (PWV), which
is a non-invasive evaluation of arterial stiffness, is a reliable indicator of vascular
function. While numerous studies have documented the benefit of dietary intervention in the
reduction of CVD related sequelae, limited data is available regarding whether the beneficial
effect of dietary intervention are reflected in vascular endothelial function. The present
study was therefore conducted to assess the effects of plant-based diet (PBD) on vascular
endothelial function as assessed by FMD and PWV in patients with peripheral arterial disease
(PAD).
Patients with peripheral arterial disease (PAD) will be included in the study. Inclusion criteria for PAD included an ankle brachial index (ABI) of 0.90 or less at baseline. Those with an ABI greater than 0.90 at baseline were eligible if a non-invasive vascular ultrasound demonstrated PAD, lower extremity angiography showed arterial stenosis of 70% or greater, or medical records documented prior revascularization of lower extremities.9 Additionally, subjects must be willing and able to maintain an on-line food journal using smartphone-based dietary apps. Once enrolled, all participants underwent baseline evaluation, after which they were enrolled in either dietary advice for plant-based diet (PBD group) or no specific dietary advice (control group). The dietary intervention was continued for four months, at the end of which a follow up evaluation was performed. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06032065 -
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD)
|
Phase 3 | |
Active, not recruiting |
NCT03987061 -
MOTIV Bioresorbable Scaffold in BTK Artery Disease
|
N/A | |
Recruiting |
NCT03506633 -
Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients
|
N/A | |
Active, not recruiting |
NCT03506646 -
Dietary Nitrate Supplementation and Thermoregulation
|
N/A | |
Active, not recruiting |
NCT04677725 -
NEtwork to Control ATherothrombosis (NEAT Registry)
|
||
Recruiting |
NCT05961943 -
RESPONSE-2-PAD to Reduce Sedentary Time in Peripheral Arterial Disease Patients
|
N/A | |
Recruiting |
NCT06047002 -
Personalised Antiplatelet Therapy for Patients With Symptomatic Peripheral Arterial Disease
|
||
Completed |
NCT03185052 -
Feasibility of Outpatient Care After Manual Compression in Patients Treated for Peripheral Arterial Disease by Endovascular Technique With 5F Sheath Femoral Approach
|
N/A | |
Recruiting |
NCT05992896 -
A Study of Loco-Regional Liposomal Bupivacaine Injection
|
Phase 4 | |
Completed |
NCT04635501 -
AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial
|
N/A | |
Recruiting |
NCT04584632 -
The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery
|
N/A | |
Withdrawn |
NCT03994185 -
The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease
|
N/A | |
Withdrawn |
NCT03538392 -
Serranator® Alto Post Market Clinical Follow Up (PMCF) Study
|
||
Recruiting |
NCT02915796 -
Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty
|
Phase 1 | |
Active, not recruiting |
NCT02900924 -
Observational Study to Evaluate the BioMimics 3D Stent System: MIMICS-3D
|
||
Completed |
NCT02901847 -
To Evaluate the Introduction of a Public Health Approach to Peripheral Arterial Disease (PAD) Using National Centre for Sport and Exercise Medicine Facilities.
|
N/A | |
Not yet recruiting |
NCT02387450 -
Reduced Cardiovascular Morbi-mortality by Sildenafil in Patients With Arterial Claudication
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT02455726 -
Magnesium Oral Supplementation to Reduce Pain Inpatients With Severe Peripheral Arterial Occlusive Disease
|
N/A | |
Withdrawn |
NCT02126540 -
Trial of Pantheris System, an Atherectomy Device That Provides Imaging While Removing Plaque in Lower Extremity Arteries
|
N/A | |
Completed |
NCT02384980 -
Saving Life and Limb: FES for the Elderly With PAD
|
Phase 1 |